Stuart H. Ralston

Active 1984–2025

Also published as
Stuart H Ralston
183
Papers
29,015
Citations
108
h-index
180
i10-index

Citations

Citations per year for Stuart H. Ralston1974: 1 citations1985: 6 citations1986: 3 citations1987: 3 citations1988: 3 citations1989: 5 citations1990: 3 citations1991: 12 citations1992: 15 citations1993: 14 citations1994: 11 citations1995: 24 citations1996: 46 citations1997: 50 citations1998: 80 citations1999: 111 citations2000: 138 citations2001: 201 citations2002: 190 citations2003: 202 citations2004: 169 citations2005: 201 citations2006: 204 citations2007: 162 citations2008: 210 citations2009: 192 citations2010: 244 citations2011: 174 citations2012: 185 citations2013: 171 citations2014: 149 citations2015: 155 citations2016: 182 citations2017: 131 citations2018: 157 citations2019: 589 citations2020: 646 citations2021: 580 citations2022: 539 citations2023: 370 citations2024: 612 citations2025: 231 citations2026: 7 citations1975–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,115 citing papers, 22.3% of this breakdownUnited Kingdom: 1,147 citing papers, 12.1% of this breakdownChina: 772 citing papers, 8.1% of this breakdownGermany: 461 citing papers, 4.9% of this breakdownItaly: 419 citing papers, 4.4% of this breakdownAustralia: 380 citing papers, 4% of this breakdownCanada: 365 citing papers, 3.9% of this breakdownNetherlands: 348 citing papers, 3.7% of this breakdownJapan: 305 citing papers, 3.2% of this breakdownFrance: 295 citing papers, 3.1% of this breakdownSpain: 192 citing papers, 2% of this breakdownSwitzerland: 187 citing papers, 2% of this breakdown
0%22.3%Other 26.3%

Fields

  • Medicine65.8%
  • Biochemistry, Genetics and Molecular Biology25.7%
  • Immunology and Microbiology2.1%
  • Neuroscience1.8%
  • Engineering1.1%
  • Nursing0.6%
  • Other2.9%

Topics

  • Bone health and osteoporosis research7.9%
  • Bone health and treatments6.5%
  • Bone Metabolism and Diseases6.5%
  • Gout, Hyperuricemia, Uric Acid2.5%
  • Osteoarthritis Treatment and Mechanisms2.1%
  • Bone and Joint Diseases2%
  • Other72.5%

Coauthors

All papers

Open in search
  1. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laurent F. Thomas, Margo Tuerlings, John Loughlin, Nigel Arden, Fraser Birrell, Andrew Carr, Panos Deloukas, Michael Doherty, Andrew W. McCaskie, William Ollier, Ashok Rai, Stuart H. Ralston, Tim D. Spector, Gillian A. Wallis, Amy E. Martinsen, Cristen J. Willer, Egil A. Fors, Ingunn Mundal, Knut Hagen, Kristian Bernhard Nilsen, Marie Udnesseter Lie, Sigrid Børte, Ben Brumpton, Jonas B. Nielsen, Lars G. Fritsche, Wei Zhou, Ingrid Heuch, Kjersti Storheim, Evangelos Tyrpenou, A. Koukakis, Dimitrios Chytas, Dimitrios Stergios Evangelopoulos, Chronopoulos Efstathios, Spiros G. Pneumaticos, Vasileios S. Nikolaou, Κonstantinos Ν. Malizos, Lydia Anastasopoulou, Gonçalo R. Abecasis, Aris Baras, Michael Cantor, Giovanni Coppola, Andrew Deubler, Aris N. Economides, Luca A. Lotta, John D. Overton, Jeffrey G. Reid, Alan R. Shuldiner, Katia Karalis, Katherine Siminovitch, Christina Beechert, Caitlin Forsythe, Erin D. Fuller, Zhenhua Gu, Michael Lattari, Alexander Lopez, Thomas D. Schleicher, Maria Sotiropoulos Padilla, Louis Widom, Sarah E. Wolf, Manasi Pradhan, Kia Manoochehri, Xiaodong Bai, Suganthi Balasubramanian, Boris Boutkov, Gisu Eom, Lukas Habegger, Alicia Hawes, Olga Krasheninina, Rouel Lanche, Adam J. Mansfield and 55 more - Cell 2021 cited by 467

  2. Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS

    Authors: , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2020 cited by 352

  3. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E. Douglas Rooke, John Thomson, M.A. Warren, Kirsty Wetherall, Robbie S. Wilson, C.P. Hall, A Maseri, H. A. Bird, Gordon Murray, James W. Dear, Mark C. Petrie, Michael P. MacDonald, Pardeep S. Jhund, Elizabeth A. Connolly, David J. Murphy, Narinder Paul, A G Olsson, P.T. Koskinen, A. Fuat, Alexis Foster, Wendy Saywood, R.J. Barr, Lewis McConnachie, Louis F. Wilson, L. Larsen Rasmussen, A.R. McGinnis, H Birrell, M. Keiller, I.S. Bremner, Gareth Forbes, Jennifer Dumbleton, Jonathan Rhodes, Theodore Waller - The Lancet 2020 cited by 342

  4. Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Karasik, Nathalie van der Velde, M. Arfan Ikram, Babette S. Zemel, Yanhua Zhou, Christian J. Carlsson, Ching‐Ti Liu, Fiona E. McGuigan, Cindy G. Boer, Klaus Bønnelykke, Stuart H. Ralston, John A. Robbins, John P. Walsh, M. Carola Zillikens, Claudia Langenberg, Ruifang Li‐Gao, Frances M. K. Williams, Tamara B. Harris, Kristina Åkesson, Rebecca D. Jackson, Gunnar Sigurðsson, Martin den Heijer, Bram C. J. van der Eerden, Jeroen van de Peppel, Timothy D. Spector, Craig E. Pennell, Bernardo Lessa Horta, Janine F. Felix, Jing Hua Zhao, Scott G. Wilson, Renée de Mutsert, Hans Bisgaard, Unnur Styrkársdóttir, Vincent W. V. Jaddoe, Eric Orwoll, Timo A. Lakka, Robert A. Scott, Struan F.A. Grant, Mattias Lorentzon, Cornelia M. van Duijn, James F. Wilson, Kari Stefansson, Bruce M. Psaty, Douglas P. Kiel, Claes Ohlsson, Evangelia Ntzani, André J. van Wijnen, Vincenzo Forgetta, Mohsen Ghanbari, John G. Logan, Graham R. Williams, J. H. Duncan Bassett, Peter I. Croucher, Εvangelos Εvangelou, André G. Uitterlinden, Cheryl L. Ackert‐Bicknell, Jonathan H. Tobias, David M. Evans, Fernando Rivadeneira - The American Journal of Human Genetics 2018 cited by 361

  5. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sagar N. Doshi, Moira Dryburgh, Michael Eddleston, Jim Finlayson, Ahmet Fuat, Jacqueline Furnace, JW Kerr Grieve, Greg Guthrie, Sharon Ham, Emma Isaard, Claudine G. Jennings, Richard J. Johnson, Claire Kerr, Sohail Khan, Kailash Krishnan, Susan Long, A. S. Mackintosh, Mary Joan MacLeod, Terry McCormack, Paul McEleny, Monique Morar, Adnan Nadir, David E. Newby, Colin J. Petrie, David Preiss, Stuart H. Ralston, Marc Randall, Helen Routledge, Saad Shakir, Raj Kumar Sharma, Bridget Shepherd, Don Sims, Gordon Snedden, Jasper Trevelyan, Christopher J. Weir, Robin A.P. Weir, Kirsty Wetherall, Robbie S. Wilson, Adam Wilson, Kris Zutis - The Lancet 2022 cited by 157

  6. Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS

    Authors: , , , , , , , , , - Bone 2017 cited by 491

  7. Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2021 cited by 145

  8. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louise A. Donnelly, Lynette D. Fairbanks, Martin Aringer, Paul McKeigue, Stuart H. Ralston, Andrew D. Morris, Pavao Rudan, Nicholas D. Hastie, Harry Campbell, Alan F. Wright - Nature Genetics 2008 cited by 806

  9. Role of the Microbiome in Regulating Bone Metabolism and Susceptibility to Osteoporosis

    Authors: , , , , , , , , , , , , , , , , , , , - Calcified Tissue International 2021 cited by 54

  10. Defective removal of ribonucleotides from DNA promotes systemic autoimmunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Markus M. Nöthen, Martin Aringer, Annegret Kuhn, Kirsten Lüthke, L. Unger, Annette Bley, Alice Lorenzi, John D. Isaacs, Dimitra Alexopoulou, Karsten Conrad, Andreas Dahl, Axel Roers, Marta E. Alarcón‐Riquelme, Andrew P. Jackson, Min Ae Lee-Kirsch - Journal of Clinical Investigation 2014 cited by 222

  11. A Randomized Trial of Vertebroplasty for Osteoporotic Spinal Fractures

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 1,426

  12. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society

    Authors: , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2019 cited by 109

  13. Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - BMC Medical Genetics 2006 cited by 312

  14. Bisphosphonates for the Prevention of Fractures in Osteogenesis Imperfecta: Meta-Analysis of Placebo-Controlled Trials

    Authors: , , , - Journal of Bone and Mineral Research 2014 cited by 131

  15. Management of Osteogenesis Imperfecta

    Authors: , - Frontiers in Endocrinology 2020 cited by 125

  16. Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - RMD Open 2021 cited by 72

  17. Nitric oxide and bone

    Authors: , - Immunology 2001 cited by 518

  18. Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis

    Authors: , , , , - Lara D. Veeken 2014 cited by 159

  19. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Osteoporosis International 2012 cited by 336

  20. Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Calcified Tissue International 2019 cited by 160

  21. Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

    Authors: , , , , , , , , , , , , , , , , - RMD Open 2023 cited by 36

  22. A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease

    Authors: , , , , , - Rheumatology International 2021 cited by 29

  23. Presentation and management of osteoporosis presenting in association with pregnancy or lactation

    Authors: , - Osteoporosis International 2015 cited by 262

  24. ER Stress-Mediated Apoptosis in a New Mouse Model of Osteogenesis imperfecta

    Authors: , , , , , , , , , , , , - PLoS Genetics 2008 cited by 166